They further assessed the relationship between TMB and specific EGFR alterations in a separate cohort of 383 EGFR mutant lung cancer cases irrespective of treatment exposure and found that EGFR 19del had a lower TMB than EGFR L858R lung tumors, which might account for the different response to ICIs (18). The gene discussed is EGFR; the disease is lung cancer.